Macrophage Endotoxin Tolerance: Tumor Necrosis Factor and Interleukin-1 Regulation by Lipopolysaccharide Pretreatment

Archives of Surgery

Volumn 129, Issue 12, 1994, Pages 1263-1270

  Seatter, Susan C ^a   Bennet, Terriel ^a   Li, Mary H ^a   Bubrick, Melvin P ^a   West, Michael A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; ESCHERICHIA COLI ENDOTOXIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 1; MESSENGER RNA; RECOMBINANT INTERLEUKIN 1; RECOMBINANT TUMOR NECROSIS FACTOR; RNA; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; BIOASSAY; CELL CULTURE; CONTROLLED STUDY; ENDOTOXEMIA; GENE EXPRESSION REGULATION; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; MACROPHAGE FUNCTION; MALE; MOUSE; NONHUMAN; NORTHERN BLOTTING; PERITONEUM MACROPHAGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANIMAL; BLOTTING, NORTHERN; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; IMMUNE TOLERANCE; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED BALB C; POLYMERASE CHAIN REACTION; PREMEDICATION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SUPPORT, U.S. GOV'T, P.H.S.; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR;

EID: 0028072227     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.1994.01420360053006     Document Type: Article

References (31)

1. Carrico CJ, Meakins JL, Fry DE, Meier RV. Multiple organ failure syndrome. Arch Surg. 1986;121:196-208.
2. Munoz C, Carlet J, Fitting C, Misset B, Bleriot JP, Cavaillon JM. Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest. 1991; 88:1747-1754.
3. Beal AL, Cerra FB. Multiple organ failure syndrome in the 1990s. JAMA. 1994; 271:226-233.
4. Johnston CA, Greisman SE. Mechanisms of endotoxin tolerance. In: Proctor RA, Hinshaw LB, eds. Pathophysiology of Endotoxin. Amsterdam, the Netherlands: Elsevier Science Publishers; 1985:359-401.
5. Sanchez-Cantu L, Rode HN, Christou NV. Endotoxin tolerance is associated with reduced secretion of tumor necrosis factor. Arch Surg. 1989;124:1432-1435.
6. Haas JG, Baeuerle PA, Riethmuller G, Ziegler-Heitbrock HWL. Molecular mechanisms in down-regulation of tumor necrosis factor expression. Proc Natl Acad Sci U S A. 1990;87:9563-9567.
7. Virca GD, Kim SY, Glaser KB, Ulevitch RJ. Lipopolysaccharide induces hyporesponsiveness to its own action in RAW 269.7 cells. J Biol Chem. 1989;130: 800-807.
8. Mathison JC, Virca GD, Wolfson E, Glaser K, Ulevitch RJ. Adaptation of bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages. J Clin Invest. 1990;85:1108-1118.
9. Wei H, Fong Y, Marano MA, et al. Tolerance to endotoxin prevents mortality in infected thermal injury: association with attenuated cytokine responses. J Infect Dis. 1992;165:859-864.
10. Fahmi H, Chaby R. Selective refractoriness of macrophages to endotoxin-induced production of tumor necrosis factor, elicited by an autocrine mechanism. J Leukoc Biol. 1993;53:45-52.
11. West MA, Manthei R, Bubrick MP. In vitro LPS pretreatment differentially regulates TNF, PGE2, and IL-1 release by macrophages. Surg Forum. 1992;53:90-92.
12. West MA, Li MH, Close K, Manthei R, Bubrick MP. Endotoxin pretreatment of human monocytes alters subsequent in vitro endotoxin-triggered TNF, IL-1, IL-6 and PGE2 release. Surg Forum. 1993;49:74-76.
13. Li MH, Seatter SC, Manthei R, Bubrick MP, West MA. Macrophage endotoxin tolerance: effect of TNF or endotoxin pretreatment. J Surg Res. 1994;57:85-92.
14. West MA, Li MH, Seatter SC, Bubrick MP. Pre-exposure to hypoxia or septic stimuli differentially regulates endotoxin release of tumor necrosis factor, interleukin-6, interleukin-1, prostaglandin E2, nitric oxide and superoxide by macrophages. J Trauma. 1994;37:82-90.
15. Aggarwal BB. Human lymphotoxin. Methods Enzymol. 1985;116:441-448.
16. Chomcyznski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162: 156-159.
17. Mullis KB, Faloona FA. Specific synthesis of DNA in vitro via a polymerase-catalysed chain reaction. Methods Enzymol. 1987;155:335-350.
18. Schochetman G, Ou C-Y, Jones WK. Polymerase chain reaction. J Infect Dis. 1988;158:1154-1157.
19. Ferre F. Quantitative or semi-quantitative PCR: reality versus myth. PCR Methods Appl. 1992;2:1-9.
20. Melby PC, Darnell BJ, Tyron VV. Quantitative measurement of human cytokine gene expression by polymerase chain reaction. J Immunol Methods. 1993; 159:235-244.
21. Zuckerman SH, Evans GF, Gutherie L. Transcriptional and post-translational mechanisms involved in the differential expression of LPS-induced IL-1 and TNF mRNA. Immunology. 1991;73:460-465.
22. Zhong WW, Burke PA, Hand AT, Walsh MJ, Hughes LA, Forse RA. Regulation of cytokine mRNA expression on lipopolysaccharide-stimulated human macrophages. Arch Surg. 1993;128:158-164.
23. Taniguchi T. Regulation of cytokine gene expression. Annu Rev Biochem. 1988; 6:439-464.
24. Deforge LE, Remick DG. Kinetics of TNF, IL-6, and IL-8 gene expression in LPS-stimulated human whole blood. Biochem Biophys Res Comm. 1991;174: 18-24.
25. Taffet SM, Pace JL, Russel SW. Lymphokine maintains macrophage activation for tumor cell killing by interfering with the negative regulatory effects of prostaglandin E2. J Immunol. 1981;127:121-124.
26. Spengler RN, Spengler ML, Strieter RM, Remick DG, Larrick JW, Kunkel SL. Modulation of tumor necrosis factor-α gene expression: desensitization of prostaglandin E2-induced suppression. J Immunol. 1989;142:4346-4350.
27. Endres S, Cannon JG, Ghorbani R, et al. In vitro production of IL-1β, IL-1α, TNF and IL-2 in healthy subjects: distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulation. Eur J Immunol. 1989;19: 2327-2333.
28. Kovacs EJ, Radzioch D, Young HA, Varesio L. Differential inhibition of IL-1 and TNF-α mRNA expression by agents which block second messenger pathways in murine macrophages. J Immunol. 1988;141:3101-3105.
29. Takasuka N, Tokunaga T, Akagawa KS. Preexposure of macrophages to low doses of lipopolysaccharide inhibits the expression of tumor necrosis factor-α mRNA but not of IL-1β mRNA. J Immunol. 1991;146:3824-3830.
30. Cavaillon JM, Pitton C, Fitting C. Endotoxin tolerance is not an LPS-specific phenomenon: partial mimicry with IL-1, IL-10, and TGF β. J Endotoxin Res. 1994;1:21-29.
31. Haas JG, Thiel C, Blomer K, et al. Down regulation of tumor necrosis factor expression in the human mono-Mac-6 cell line by lipopolysaccharide. J Leukoc Biol. 1989;43:11-14.